Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Post by jwalliscaon Apr 04, 2020 6:03pm
129 Views
Post# 30879617

DF Post# 30879539; thanks for your reply

DF Post# 30879539; thanks for your replyDF:

I apprecite you making the time for a reply. That said, much is vague with your language in how you have written it. Perhaps you don't understand that what you intended to say is not said by the words you wrote.

You are making many assumptions that are not accurate, nor have you given any supporting evidence to what I asked despite posting as if you are a pharmaceutical expert.

Further, yes, I have actually been on the BOD of a junior company. What you are implying in obtuse language is something I don't get, period.

It would be nice for a BB readers for you to share your expertise on pharmaceuticals. Innuendo and inference without substance don't cut it.

You bash Dr. Toleikis for the long ago Edmonton experience, but you praise him in other regards. Have you always made the right decision in your life moving forward, or did you, like most of us, work your plan when the initial approach turned out to not be what you expected?

If we always had the benfit of hindsight, we would do much better when we scope our foresight.

Regarding Dr. Toleikis's approach to business development, how can you improve upon succeding in a FDA trial using your crown jewel?  Dr. Toleikis knew exactly what is needeed to get The pouch to a marketable status. You seem to not even understand that.

Please provide substance rather than obtuse wording should you choose to make further BB posts

Thank you,
jwall



Bullboard Posts